▶ 調査レポート

ワクチンの世界市場 2020年

• 英文タイトル:Global Vaccine Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ワクチンの世界市場 2020年 / Global Vaccine Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201115342資料のイメージです。• レポートコード:GIR201115342
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、121ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、ワクチンの世界市場を調査対象にし、ワクチンの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(水痘ワクチン、インフルエンザワクチン、ポリオワクチン、A型肝炎ワクチン、狂犬病ワクチン、BCGワクチン、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他)、用途別分析(大人用、子供用)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:AstraZeneca、GSK、CCBIO、BioNTech、Elanco、Boehringer-Ingelheim、Indian Immunologicals、CureVac、CSL、Hulan Bio、Mylan、Translate Bio、Merck、Wuhan Institute of Biological Products、Plumbline Life Sciences、Moderna Therapeutics、Minhai Biotechnology、Walvax Biotechnology、Sanofi、Mitsubishi Tanabe Pharma、Zoties
・企業別売上、市場シェア
・ワクチンの地域別市場分析
・ワクチンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・ワクチンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・ワクチンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・ワクチンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・ワクチンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・ワクチンの種類別市場規模2015-2020:水痘ワクチン、インフルエンザワクチン、ポリオワクチン、A型肝炎ワクチン、狂犬病ワクチン、BCGワクチン、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他
・ワクチンの用途別市場規模2015-2020:大人用、子供用
・ワクチンの世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Vaccine market has been segmented into:
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others

By Application, Vaccine has been segmented into:
For Adult
For Child

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Vaccine Market Share Analysis
Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Vaccine are:
AstraZeneca
GSK
CCBIO
BioNTech
Elanco
Boehringer-Ingelheim
Indian Immunologicals
CureVac
CSL
Hulan Bio
Mylan
Translate Bio
Merck
Wuhan Institute of Biological Products
Plumbline Life Sciences
Moderna Therapeutics
Minhai Biotechnology
Walvax Biotechnology
Sanofi
Mitsubishi Tanabe Pharma
Zoties
Among other players domestic and global, Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Vaccine Market Overview
1.1 Product Overview and Scope of Vaccine
1.2 Classification of Vaccine by Type
1.2.1 Global Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Vaccine Revenue Market Share by Type in 2019
1.2.3 Varicella Vaccine
1.2.4 Influenza Vaccine
1.2.5 Polio Vaccine
1.2.6 Hepatitis A Vaccine
1.2.7 Rabies Vaccine
1.2.8 BCG Vaccine
1.2.9 Hepatitis B
1.2.10 Pertussis, Diphtheria, tetanus
1.2.11 Pneumococcal
1.2.12 Others
1.3 Global Vaccine Market by Application
1.3.1 Overview: Global Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Adult
1.3.3 For Child
1.4 Global Vaccine Market by Regions
1.4.1 Global Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Vaccine Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK SWOT Analysis
2.2.4 GSK Product and Services
2.2.5 GSK Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 CCBIO
2.3.1 CCBIO Details
2.3.2 CCBIO Major Business
2.3.3 CCBIO SWOT Analysis
2.3.4 CCBIO Product and Services
2.3.5 CCBIO Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech SWOT Analysis
2.4.4 BioNTech Product and Services
2.4.5 BioNTech Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Elanco
2.5.1 Elanco Details
2.5.2 Elanco Major Business
2.5.3 Elanco SWOT Analysis
2.5.4 Elanco Product and Services
2.5.5 Elanco Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer-Ingelheim
2.6.1 Boehringer-Ingelheim Details
2.6.2 Boehringer-Ingelheim Major Business
2.6.3 Boehringer-Ingelheim Product and Services
2.6.4 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals Product and Services
2.7.4 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.8 CureVac
2.8.1 CureVac Details
2.8.2 CureVac Major Business
2.8.3 CureVac Product and Services
2.8.4 CureVac Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.9 CSL
2.9.1 CSL Details
2.9.2 CSL Major Business
2.9.3 CSL Product and Services
2.9.4 CSL Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hulan Bio
2.10.1 Hulan Bio Details
2.10.2 Hulan Bio Major Business
2.10.3 Hulan Bio Product and Services
2.10.4 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Product and Services
2.11.4 Mylan Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Translate Bio
2.12.1 Translate Bio Details
2.12.2 Translate Bio Major Business
2.12.3 Translate Bio Product and Services
2.12.4 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business
2.13.3 Merck Product and Services
2.13.4 Merck Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.14 Wuhan Institute of Biological Products
2.14.1 Wuhan Institute of Biological Products Details
2.14.2 Wuhan Institute of Biological Products Major Business
2.14.3 Wuhan Institute of Biological Products Product and Services
2.14.4 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.15 Plumbline Life Sciences
2.15.1 Plumbline Life Sciences Details
2.15.2 Plumbline Life Sciences Major Business
2.15.3 Plumbline Life Sciences Product and Services
2.15.4 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.16 Moderna Therapeutics
2.16.1 Moderna Therapeutics Details
2.16.2 Moderna Therapeutics Major Business
2.16.3 Moderna Therapeutics Product and Services
2.16.4 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.17 Minhai Biotechnology
2.17.1 Minhai Biotechnology Details
2.17.2 Minhai Biotechnology Major Business
2.17.3 Minhai Biotechnology Product and Services
2.17.4 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.18 Walvax Biotechnology
2.18.1 Walvax Biotechnology Details
2.18.2 Walvax Biotechnology Major Business
2.18.3 Walvax Biotechnology Product and Services
2.18.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sanofi
2.19.1 Sanofi Details
2.19.2 Sanofi Major Business
2.19.3 Sanofi Product and Services
2.19.4 Sanofi Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.20 Mitsubishi Tanabe Pharma
2.20.1 Mitsubishi Tanabe Pharma Details
2.20.2 Mitsubishi Tanabe Pharma Major Business
2.20.3 Mitsubishi Tanabe Pharma Product and Services
2.20.4 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.21 Zoties
2.21.1 Zoties Details
2.21.2 Zoties Major Business
2.21.3 Zoties Product and Services
2.21.4 Zoties Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Vaccine Players Market Share
3.2.2 Top 10 Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Vaccine Revenue and Market Share by Regions
4.2 North America Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Vaccine Revenue and Growth Rate (2015-2020)
5 North America Vaccine Revenue by Countries
5.1 North America Vaccine Revenue by Countries (2015-2020)
5.2 USA Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico Vaccine Revenue and Growth Rate (2015-2020)
6 Europe Vaccine Revenue by Countries
6.1 Europe Vaccine Revenue by Countries (2015-2020)
6.2 Germany Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK Vaccine Revenue and Growth Rate (2015-2020)
6.4 France Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Vaccine Revenue by Countries
7.1 Asia-Pacific Vaccine Revenue by Countries (2015-2020)
7.2 China Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea Vaccine Revenue and Growth Rate (2015-2020)
7.5 India Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine Revenue and Growth Rate (2015-2020)
8 South America Vaccine Revenue by Countries
8.1 South America Vaccine Revenue by Countries (2015-2020)
8.2 Brazil Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Vaccine by Countries
9.1 Middle East & Africa Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global Vaccine Market Forecast by Type (2019-2024)
10.3 Varicella Vaccine Revenue Growth Rate (2015-2025)
10.4 Influenza Vaccine Revenue Growth Rate (2015-2025)
10.5 Polio Vaccine Revenue Growth Rate (2015-2025)
10.6 Hepatitis A Vaccine Revenue Growth Rate (2015-2025)
10.7 Rabies Vaccine Revenue Growth Rate (2015-2025)
10.8 BCG Vaccine Revenue Growth Rate (2015-2025)
10.9 Hepatitis B Revenue Growth Rate (2015-2025)
10.10 Pertussis, Diphtheria, tetanus Revenue Growth Rate (2015-2025)
10.11 Pneumococcal Revenue Growth Rate (2015-2025)
10.12 Others Revenue Growth Rate (2015-2025)
11 Global Vaccine Market Segment by Application
11.1 Global Vaccine Revenue Market Share by Application (2015-2020)
11.2 Vaccine Market Forecast by Application (2019-2024)
11.3 For Adult Revenue Growth (2015-2020)
11.4 For Child Revenue Growth (2015-2020)
12 Global Vaccine Market Size Forecast (2021-2025)
12.1 Global Vaccine Market Size Forecast (2021-2025)
12.2 Global Vaccine Market Forecast by Regions (2021-2025)
12.3 North America Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Vaccine Revenue Market Forecast (2021-2025)
12.6 South America Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. AstraZeneca Corporate Information, Location and Competitors
Table 7. AstraZeneca Vaccine Major Business
Table 8. AstraZeneca Vaccine Total Revenue (USD Million) (2017-2018)
Table 9. AstraZeneca SWOT Analysis
Table 10. AstraZeneca Vaccine Product and Solutions
Table 11. AstraZeneca Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. GSK Corporate Information, Location and Competitors
Table 13. GSK Vaccine Major Business
Table 14. GSK Vaccine Total Revenue (USD Million) (2018-2019)
Table 15. GSK SWOT Analysis
Table 16. GSK Vaccine Product and Solutions
Table 17. GSK Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. CCBIO Corporate Information, Location and Competitors
Table 19. CCBIO Vaccine Major Business
Table 20. CCBIO Vaccine Total Revenue (USD Million) (2017-2018)
Table 21. CCBIO SWOT Analysis
Table 22. CCBIO Vaccine Product and Solutions
Table 23. CCBIO Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. BioNTech Corporate Information, Location and Competitors
Table 25. BioNTech Vaccine Major Business
Table 26. BioNTech Vaccine Total Revenue (USD Million) (2017-2018)
Table 27. BioNTech SWOT Analysis
Table 28. BioNTech Vaccine Product and Solutions
Table 29. BioNTech Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Elanco Corporate Information, Location and Competitors
Table 31. Elanco Vaccine Major Business
Table 32. Elanco Vaccine Total Revenue (USD Million) (2017-2018)
Table 33. Elanco SWOT Analysis
Table 34. Elanco Vaccine Product and Solutions
Table 35. Elanco Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Boehringer-Ingelheim Corporate Information, Location and Competitors
Table 37. Boehringer-Ingelheim Vaccine Major Business
Table 38. Boehringer-Ingelheim Vaccine Total Revenue (USD Million) (2017-2018)
Table 39. Boehringer-Ingelheim SWOT Analysis
Table 40. Boehringer-Ingelheim Vaccine Product and Solutions
Table 41. Boehringer-Ingelheim Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Indian Immunologicals Corporate Information, Location and Competitors
Table 43. Indian Immunologicals Vaccine Major Business
Table 44. Indian Immunologicals Vaccine Total Revenue (USD Million) (2017-2018)
Table 45. Indian Immunologicals SWOT Analysis
Table 46. Indian Immunologicals Vaccine Product and Solutions
Table 47. Indian Immunologicals Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. CureVac Corporate Information, Location and Competitors
Table 49. CureVac Vaccine Major Business
Table 50. CureVac Vaccine Total Revenue (USD Million) (2017-2018)
Table 51. CureVac SWOT Analysis
Table 52. CureVac Vaccine Product and Solutions
Table 53. CureVac Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. CSL Corporate Information, Location and Competitors
Table 55. CSL Vaccine Major Business
Table 56. CSL Vaccine Total Revenue (USD Million) (2017-2018)
Table 57. CSL SWOT Analysis
Table 58. CSL Vaccine Product and Solutions
Table 59. CSL Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Hulan Bio Corporate Information, Location and Competitors
Table 61. Hulan Bio Vaccine Major Business
Table 62. Hulan Bio Vaccine Total Revenue (USD Million) (2017-2018)
Table 63. Hulan Bio SWOT Analysis
Table 64. Hulan Bio Vaccine Product and Solutions
Table 65. Hulan Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Mylan Corporate Information, Location and Competitors
Table 67. Mylan Vaccine Major Business
Table 68. Mylan Vaccine Total Revenue (USD Million) (2017-2018)
Table 69. Mylan SWOT Analysis
Table 70. Mylan Vaccine Product and Solutions
Table 71. Mylan Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Translate Bio Corporate Information, Location and Competitors
Table 73. Translate Bio Vaccine Major Business
Table 74. Translate Bio Vaccine Total Revenue (USD Million) (2017-2018)
Table 75. Translate Bio SWOT Analysis
Table 76. Translate Bio Vaccine Product and Solutions
Table 77. Translate Bio Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Merck Corporate Information, Location and Competitors
Table 79. Merck Vaccine Major Business
Table 80. Merck Vaccine Total Revenue (USD Million) (2017-2018)
Table 81. Merck SWOT Analysis
Table 82. Merck Vaccine Product and Solutions
Table 83. Merck Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Wuhan Institute of Biological Products Corporate Information, Location and Competitors
Table 85. Wuhan Institute of Biological Products Vaccine Major Business
Table 86. Wuhan Institute of Biological Products Vaccine Total Revenue (USD Million) (2017-2018)
Table 87. Wuhan Institute of Biological Products SWOT Analysis
Table 88. Wuhan Institute of Biological Products Vaccine Product and Solutions
Table 89. Wuhan Institute of Biological Products Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Plumbline Life Sciences Corporate Information, Location and Competitors
Table 91. Plumbline Life Sciences Vaccine Major Business
Table 92. Plumbline Life Sciences Vaccine Total Revenue (USD Million) (2017-2018)
Table 93. Plumbline Life Sciences SWOT Analysis
Table 94. Plumbline Life Sciences Vaccine Product and Solutions
Table 95. Plumbline Life Sciences Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Moderna Therapeutics Corporate Information, Location and Competitors
Table 97. Moderna Therapeutics Vaccine Major Business
Table 98. Moderna Therapeutics Vaccine Total Revenue (USD Million) (2017-2018)
Table 99. Moderna Therapeutics SWOT Analysis
Table 100. Moderna Therapeutics Vaccine Product and Solutions
Table 101. Moderna Therapeutics Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Minhai Biotechnology Corporate Information, Location and Competitors
Table 103. Minhai Biotechnology Vaccine Major Business
Table 104. Minhai Biotechnology Vaccine Total Revenue (USD Million) (2017-2018)
Table 105. Minhai Biotechnology SWOT Analysis
Table 106. Minhai Biotechnology Vaccine Product and Solutions
Table 107. Minhai Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Walvax Biotechnology Vaccine Type and Application
Table 109. Walvax Biotechnology Vaccine Major Business
Table 110. Walvax Biotechnology Vaccine Total Revenue (USD Million) (2017-2018)
Table 111. Walvax Biotechnology SWOT Analysis
Table 112. Walvax Biotechnology Vaccine Product and Solutions
Table 113. Walvax Biotechnology Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Sanofi Corporate Information, Location and Competitors
Table 115. Sanofi Vaccine Major Business
Table 116. Sanofi Vaccine Total Revenue (USD Million) (2017-2018)
Table 117. Sanofi SWOT Analysis
Table 118. Sanofi Vaccine Product and Solutions
Table 119. Sanofi Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Mitsubishi Tanabe Pharma Corporate Information, Location and Competitors
Table 121. Mitsubishi Tanabe Pharma Vaccine Major Business
Table 122. Mitsubishi Tanabe Pharma Vaccine Total Revenue (USD Million) (2017-2018)
Table 123. Mitsubishi Tanabe Pharma SWOT Analysis
Table 124. Mitsubishi Tanabe Pharma Vaccine Product and Solutions
Table 125. Mitsubishi Tanabe Pharma Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Zoties Corporate Information, Location and Competitors
Table 127. Zoties Vaccine Major Business
Table 128. Zoties Vaccine Total Revenue (USD Million) (2017-2018)
Table 129. Zoties SWOT Analysis
Table 130. Zoties Vaccine Product and Solutions
Table 131. Zoties Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Global Vaccine Revenue (Million USD) by Players (2015-2020)
Table 133. Global Vaccine Revenue Share by Players (2015-2020)
Table 134. Global Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 135. Global Vaccine Revenue Market Share by Regions (2015-2020)
Table 136. North America Vaccine Revenue by Countries (2015-2020)
Table 137. North America Vaccine Revenue Market Share by Countries (2015-2020)
Table 138. Europe Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 139. Asia-Pacific Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 140. South America Vaccine Revenue by Countries (2015-2020)
Table 141. South America Vaccine Revenue Market Share by Countries (2015-2020)
Table 142. Middle East and Africa Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 143. Middle East and Africa Vaccine Revenue Market Share by Countries (2015-2020)
Table 144. Global Vaccine Revenue (Million USD) by Type (2015-2020)
Table 145. Global Vaccine Revenue Share by Type (2015-2020)
Table 146. Global Vaccine Revenue Forecast by Type (2021-2025)
Table 147. Global Vaccine Revenue by Application (2015-2020)
Table 148. Global Vaccine Revenue Share by Application (2015-2020)
Table 149. Global Vaccine Revenue Forecast by Application (2021-2025)
Table 150. Global Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Vaccine Picture
Figure 2. Global Vaccine Revenue Market Share by Type in 2019
Figure 3. Varicella Vaccine Picture
Figure 4. Influenza Vaccine Picture
Figure 5. Polio Vaccine Picture
Figure 6. Hepatitis A Vaccine Picture
Figure 7. Rabies Vaccine Picture
Figure 8. BCG Vaccine Picture
Figure 9. Hepatitis B Picture
Figure 10. Pertussis, Diphtheria, tetanus Picture
Figure 11. Pneumococcal Picture
Figure 12. Others Picture
Figure 13. Vaccine Revenue Market Share by Application in 2019
Figure 14. For Adult Picture
Figure 15. For Child Picture
Figure 16. Global Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Vaccine Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Vaccine Revenue Market Share in 2019
Figure 25. Global Top 10 Players Vaccine Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Vaccine Revenue Market Share by Regions (2015-2020)
Figure 29. Global Vaccine Revenue Market Share by Regions in 2018
Figure 30. North America Vaccine Revenue and Growth Rate (2015-2020)
Figure 31. Europe Vaccine Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Vaccine Revenue and Growth Rate (2015-2020)
Figure 33. South America Vaccine Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. North America Vaccine Revenue Market Share by Countries (2015-2020)
Figure 36. North America Vaccine Revenue Market Share by Countries in 2019
Figure 37. USA Vaccine Revenue and Growth Rate (2015-2020)
Figure 38. Canada Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Vaccine Revenue and Growth Rate (2015-2020)
Figure 40. Europe Vaccine Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Vaccine Revenue Market Share by Countries in 2019
Figure 42. Germany Vaccine Revenue and Growth Rate (2015-2020)
Figure 43. UK Vaccine Revenue and Growth Rate (2015-2020)
Figure 44. France Vaccine Revenue and Growth Rate (2015-2020)
Figure 45. Russia Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. Italy Vaccine Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Vaccine Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Vaccine Revenue Market Share by Countries in 2019
Figure 49. China Vaccine Revenue and Growth Rate (2015-2020)
Figure 50. Japan Vaccine Revenue and Growth Rate (2015-2020)
Figure 51. Korea Vaccine Revenue and Growth Rate (2015-2020)
Figure 52. India Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Vaccine Revenue and Growth Rate (2015-2020)
Figure 54. South America Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. South America Vaccine Revenue Market Share by Countries in 2019
Figure 56. Brazil Vaccine Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Vaccine Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Vaccine Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Vaccine Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Vaccine Revenue and Growth Rate (2015-2020)
Figure 61. UAE Vaccine Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Vaccine Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Vaccine Revenue and Growth Rate (2015-2020)
Figure 64. Global Vaccine Revenue Share by Type (2015-2020)
Figure 65. Global Vaccine Revenue Share by Type in 2019
Figure 66. Global Vaccine Market Share Forecast by Type (2021-2025)
Figure 67. Global Varicella Vaccine Revenue Growth Rate (2015-2020)
Figure 68. Global Influenza Vaccine Revenue Growth Rate (2015-2020)
Figure 69. Global Polio Vaccine Revenue Growth Rate (2015-2020)
Figure 70. Global Hepatitis A Vaccine Revenue Growth Rate (2015-2020)
Figure 71. Global Rabies Vaccine Revenue Growth Rate (2015-2020)
Figure 72. Global BCG Vaccine Revenue Growth Rate (2015-2020)
Figure 73. Global Hepatitis B Revenue Growth Rate (2015-2020)
Figure 74. Global Pertussis, Diphtheria, tetanus Revenue Growth Rate (2015-2020)
Figure 75. Global Pneumococcal Revenue Growth Rate (2015-2020)
Figure 76. Global Others Revenue Growth Rate (2015-2020)
Figure 77. Global Vaccine Revenue Share by Application (2015-2020)
Figure 78. Global Vaccine Revenue Share by Application in 2019
Figure 79. Global Vaccine Market Share Forecast by Application (2021-2025)
Figure 80. Global For Adult Revenue Growth Rate (2015-2020)
Figure 81. Global For Child Revenue Growth Rate (2015-2020)
Figure 82. Global Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Vaccine Revenue Market Forecast (2021-2025)
Figure 86. Europe Vaccine Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Vaccine Revenue Market Forecast (2021-2025)
Figure 88. South America Vaccine Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Vaccine Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel